Catalyst Wire Dossier Catalyst Wire Dossier

MK0826

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0826, covering 2010-07-09 to 2010-07-09. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054) [Phase 3]

See pricing